COMPANY NEWS


Indoco Remedies Ltd
BSE Code 532612 ISIN Demat INE873D01024 Book Value (₹) 115.72 NSE Symbol INDOCO Div & Yield % 0.47 Market Cap ( Cr.) 2,948.45 P/E * 26.68 EPS * 11.99 Face Value (₹) 2
* Profit to Earning Ratio
* Earning Per Share
Indoco Remedies receives USFDA tentative approval for Canagliflozin Tablets Back
(06 Dec 2023)
Indoco Remedies announced the receipt of tentative approval from the USFDA for Abbreviated New Drug Application (ANDA) for Canagliflozin Tablets 100 mg and 300 mg, a generic equivalent of the Reference Listed Drug, Invokana® Tablets 100 mg and 300 mg, of Janssen Pharmaceuticals, Inc.

This product will be manufactured by Indoco Remedies, at their manufacturing facility located at Goa (Plant -I) in India.

Canagliflozin improves glycemic control in adults with type 2 diabetes mellitus.